NEW YORK – Pacific Biosciences said on Monday that it is collaborating with Corteva Agriscience to develop custom workflows for plant, pest, and microbial sequencing.
Under the terms of the project, the partners will establish high-throughput workflows for DNA extraction and library preparation to enable sequencing of thousands of samples.
"This collaboration will allow us to help Corteva Agriscience characterize complex plant and microbial genomes more efficiently," PacBio President and CEO Christian Henry said in a statement.
"We see great potential in digital technologies, new seed product development tools like CRISPR-Cas gene editing, and the next generation of crop protection solutions," Greg May, Genomics Technologies lead at Corteva Agriscience, said in a statement. "Genome sequencing technology, especially when it has both long read lengths and high accuracy, is a key tool to unlocking the potential in these development areas. Using this technology at scale can help speed up the research and product development process."
Indianapolis-based Corteva is a publicly traded agricultural chemical and seed company that was spun off by DowDuPont in 2019.
The companies hope to finish their first phase of development, on sample prep, in the third quarter.
In Monday morning trading on the Nasdaq, shares of PacBio were up 3 percent at $9.76.